Three cases of COVID-19 pneumonia treated with ivermectin monotherapy

Abstract

We report three cases of coronavirus disease 2019 (COVID-19) pneumonia treated with ivermectin monotherapy. The patients included two men (aged 40 and 49 years) and a woman (aged 53 years), all of whom had high fever and bilateral pneumonia. We administered 0.2 mg/kg of ivermectin orally every alternate day. They defervesced soon after, the blood inflammatory markers and chest radiographic findings improved and the patients were discharged. There was no need for additional therapy. These three patients improved following ivermectin administration. Oral ivermectin may have a role to play in the home treatment of COVID-19 patients.